INCY 25 Pill - white oval, 18mm
Generic Name: ruxolitinib
Pill with imprint INCY 25 is White, Oval and has been identified as Jakafi 25 mg. It is supplied by Incyte Corporation.
Jakafi is used in the treatment of Polycythemia Vera; Myelofibrosis; Myeloproliferative Disorders; Graft Versus Host Disease and belongs to the drug class multikinase inhibitors. Risk cannot be ruled out during pregnancy. Jakafi 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for INCY 25
Jakafi
- Generic Name
- ruxolitinib
- Imprint
- INCY 25
- Strength
- 25 mg
- Color
- White
- Size
- 18.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Incyte Corporation
- National Drug Code (NDC)
- 50881-0025
- Inactive Ingredients
-
microcrystalline cellulose,
lactose monohydrate,
silicon dioxide,
hydroxypropyl cellulose (type e),
povidone,
sodium starch glycolate type A potato,
magnesium stearate
Note: Inactive ingredients may vary.
See also:
Besremi
Besremi (ropeginterferon alfa-2b-njft) is used for the treatment of adults with polycythemia vera ...
Alecensa
Alecensa (alectinib) is an oral kinase inhibitor that may be used to treat certain types of ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Alunbrig
Alunbrig (brigatinib) is used to treat anaplastic lymphoma kinase-positive (ALK+) metastatic ...
Augtyro
Augtyro (repotrectinib) is a next-generation TKI (Tyrosine Kinase Inhibitor) cancer medicine used ...
Ayvakit
Ayvakit (avapritinib) is a prescription medicine used for the treatment of gastrointestinal stromal ...
Balversa
Balversa (erdafitinib) is an oral kinase inhibitor that may be used to treat adults with locally ...
Braftovi
Braftovi is a targeted cancer treatment used in combination with Mektovi, mFOLFOX6, or Erbitux, to ...
Cabometyx
Cabometyx is used to treat advanced kidney cancer, liver cancer, thyroid cancer, and pancreatic and ...
More about Jakafi (ruxolitinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (33)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.